APOA5 and metabolic dysfunction-associated steatotic liver disease: Earlier studies implicated apoA5 as a key regulator of plasma TG homeostasis [5, 6], while recent data identified its role in the biogenesis of hepatocyte lipid droplets [7-9], a histological hallmark of NAFLD.